USE OF FTORAFUR IN COMBINED TREATMENT OF BREAST CANCER

The paper presents findings on efficacy and toxicity of Ftorafur when used in polychemotherapy (СМF and CAF regimes, combination with Paclitaxel) of patients with disseminated breast cancer. Peroral use of capsulated Ftorafur is shown to be efficient and low- toxic and helps prevent inconveniences dealing with prolonged infusion of fluorouracil.



No comments » Add comment